Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
London, United Kingdom
SEC filing record 1 source field available
Fiscal year end
31 December
Autolus Therapeutics plc has filed 315 SEC EDGAR filings since 09 Feb 2018

SEC filing history

Showing 151-175 of 315 matching filings.

Per page
25
Current page
7
SC 13G File 005-90550

TETRAGON FINANCIAL MANAGEMENT LP

Filing date
20 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
14 Mar 2023
Reporting date
14 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
F-6EF File 333-270183

F-6EF filing

Filing date
01 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90550

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90550

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90550

SC 13G filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90550

SC 13G/A

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90550

SC 13G/A filing

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-90550

SEC SCHEDULE 13G

Filing date
13 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
23 Jan 2023
Reporting date
23 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
21 Dec 2022
Reporting date
21 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90550

SC 13G filing

Filing date
19 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90550

SC 13D/A

Filing date
13 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-90550

ACQUISITION OF BENEFICIAL OWNERSHIP

Filing date
13 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
12 Dec 2022
Reporting date
09 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258556

424B5

Filing date
12 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
08 Dec 2022
Reporting date
08 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-258556

424B5

Filing date
08 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K/A File 001-38547

6-K/A

Filing date
21 Nov 2022
Reporting date
30 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-90550

AMENDMENT NO. 8 TO SCHEDULE 13D

Filing date
05 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
01 Jul 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-38547

6-K

Filing date
01 Jun 2022
Reporting date
01 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .